危重老年患者住院去向对6个月结局的影响:ICE-CUB2临床试验分析
该研究对ICE-CUB2随机前瞻性多中心临床试验数据进行二次分析,纳入急诊就诊时病情危重、年龄≥75岁、ADL≥4、营养状态保留且无活动性癌症的老年患者。共3036例患者中,1448例(47%)入住ICU、504例入住IMCU(17%)、1084例入住AMW(36%)。6个月死亡率分别为ICU 44%、IMCU 31%、AMW 45%(p<0.001);多因素分析显示AMW入住较IMCU入住6个月生存更差(HR 1.31,95%CI 1.04-1.63),ICU与IMCU之间生存无显著差异(HR 1.17,95%CI 0.95-1.46)。住院去向与ADL下降1分或死亡的复合终点无显著关联;AMW组SF-12生理和心理评分低于ICU组和IMCU组。作者认为结果需在专门研究中确认,并提出设立老年专用IMCU的问题。
要点
- 危重老年患者入住AMW较IMCU 6个月生存更差(HR 1.31,95%CI 1.04-1.63),调整年龄、性别、合并症、ADL、SAPS-3和诊断后仍显著。
- 入住ICU与IMCU的6个月生存无显著差异(HR 1.17,95%CI 0.95-1.46)。
- 6个月死亡率:ICU 44%(629例)、IMCU 31%(155例)、AMW 45%(489例),p<0.001。
- 住院去向与ADL下降1分或死亡的复合终点无显著关联。
- AMW组SF-12生理评分34.3(27.5-41.7)、心理评分44.3(38.6-48.6),分别低于ICU组(34.7[28.4-45.3]、45.5[40.0-50.0])和IMCU组(35.7[29.7-43.8]、44.5[39.7-48.4]),p=0.037和p=0.028。
适用人群与场景
- ICE-CUB2试验纳入标准:在急诊科就诊时病情危重、年龄≥75岁、ADL≥4、营养状态保留、无活动性癌症的老年患者。
- 数据来自随机前瞻性多中心临床试验ICE-CUB2的二次分析。
研究设计与关键结果
- 研究类型:随机前瞻性多中心临床试验ICE-CUB2的二次分析;样本量3036例,女性1675例(55%),中位年龄85[81-99]岁,SAPS-3 62[55-69]。
- 住院去向分布:ICU 1448例(47%)、IMCU 504例(17%)、AMW 1084例(36%)。
- 6个月死亡率:ICU 44%(629例)、IMCU 31%(155例)、AMW 45%(489例),p<0.001。
- 多因素分析(调整年龄、性别、合并症、ADL、SAPS-3和诊断):AMW入住较IMCU入住6个月生存更差(HR 1.31,95%CI 1.04-1.63);ICU与IMCU之间生存无显著差异(HR 1.17,95%CI 0.95-1.46)。
- 采用多重插补处理缺失数据和倾向性评分匹配的敏感性分析结果相似。
- 住院去向与ADL下降1分或死亡的复合终点无显著关联。
- SF-12生理评分:AMW组34.3(27.5-41.7)低于ICU组34.7(28.4-45.3)和IMCU组35.7(29.7-43.8),p=0.037;心理评分:AMW组44.3(38.6-48.6)低于ICU组45.5(40.0-50.0)和IMCU组44.5(39.7-48.4),p=0.028。
证据类型、等级与局限
- 证据类型:随机前瞻性多中心临床试验的二次分析。
- 局限:作者结论指出结果需在专门研究中确认,并提出设立老年专用IMCU的问题。
对床旁实践的改变
- 作者认为,在危重老年患者中,入住AMW与较IMCU更差的6个月生存相关,ICU与IMCU之间生存无差异,各群体生活质量无临床相关差异;这些结果需在专门研究中确认,并提出设立老年专用IMCU的问题。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Little is known about the impact of hospital trajectory on survival and functional decline of older critically ill patients. We evaluate 6-month outcomes after admission to: intensive care units (ICU), intermediate care units (IMCU) or acute medical wards (AMW).
METHODS: Data from the randomised prospective multicentre clinical trial ICE-CUB2 was secondarily analysed. Inclusion criteria were: presenting at emergency departments in critical condition; age ≥ 75 years; activity of daily living (ADL) ≥ 4; preserved nutritional status; and no active cancer. A Cox model was fitted to compare survival according to admission destination adjusting for patient characteristics. Sensitivity analysis using multiple imputation for missing data and propensity score matching were performed.
RESULTS: Among 3036 patients, 1675 (55%) were women; median age was 85 [81-99] years; simplified acute physiology score (SAPS-3) 62 [55-69]; 1448 (47%) were hospitalised in an ICU, 504 in IMCU (17%), and 1084 (36%) in AMW. Six-month mortality was 629 (44%), 155 (31%) and 489 (45%) after admission in an ICU, IMCU and AMW (p < 0.001), respectively. In multivariate analysis, AMW admission was associated with worse 6-month survival (HR 1.31, 95% CI 1.04-1.63) in comparison with IMCU admission, after adjusting for age, gender, comorbidities, ADL, SAPS-3 and diagnosis. Survival was not significantly different between patients admitted in an ICU and an IMCU (HR 1.17, 95% CI 0.95-1.46). Sensitivity analysis using multiple imputation for missing data and propensity score matching found similar results. Hospital destination was not significantly associated with the composite criterion loss of 1-point ADL or mortality. Physical and mental components of the 12-Item Short-Form Health Survey were significantly lower in the acute medical ward group (34.3 [27.5-41.7], p = 0.037 and 44.3 [38.6-48.6], p = 0.028, respectively) than in the ICU group (34.7 [28.4-45.3] and 45.5 [40.0-50.0], respectively) and IMCU group (35.7 [29.7-43.8] and 44.5 [39.7-48.4], respectively).
CONCLUSIONS: Admission in an AMW was associated with worse 6-month survival in older critically ill patients in comparison with IMCU admission, with no difference of survival between ICU and IMCU admission. There were no clinically relevant differences in quality of life in each group. These results should be confirmed in specific studies and raise the question of dedicated geriatric IMCUs.
参考来源
- Thietart S, Boumendil A, Pateron D, et al. Impact on 6-month outcomes of hospital trajectory in critically ill older patients: analysis of the ICE-CUB2 clinical trial. Ann Intensive Care. 2022. PMID: 35819563. doi:10.1186/s13613-022-01042-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。